What is Universal Arts Compounding Pharmacy?
Universal Arts Compounding Pharmacy operates as a specialized healthcare provider focused on the delivery of high-quality compounded medications tailored to individual patient requirements. The company distinguishes itself through a hybrid model that integrates traditional pharmaceutical expertise with modern digital health tools, including mobile application support and wellness-oriented educational programming. By prioritizing personalized care and customized therapeutic solutions, the organization addresses critical gaps in standard medication delivery, catering to a demographic that demands precision and attentive service. Their market position is reinforced by a commitment to clinical excellence and a patient-centric approach that transcends the limitations of conventional retail pharmacy chains.
How much funding has Universal Arts Compounding Pharmacy raised?
Universal Arts Compounding Pharmacy has raised a total of $443K across 2 funding rounds:
Debt
$150K
Debt
$293K
Debt (2020): $150K with participation from PPP
Debt (2021): $293K led by PPP
Key Investors in Universal Arts Compounding Pharmacy
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Universal Arts Compounding Pharmacy?
With the successful completion of this late-stage financing round, Universal Arts Compounding Pharmacy is expected to accelerate its strategic initiatives aimed at scaling its compounding infrastructure and enhancing its digital service ecosystem. The capital will likely be deployed to optimize supply chain efficiencies, invest in advanced compounding technology, and broaden the reach of its wellness-focused service offerings. As the pharmacy navigates the complexities of the healthcare market, this infusion of resources provides the necessary runway to pursue aggressive growth targets and maintain its competitive edge in the personalized medicine industry. Future developments will likely focus on deepening market penetration and exploring new avenues for patient engagement through technological integration.
See full Universal Arts Compounding Pharmacy company page
